Final answer:
The purpose of DHA-IPM 18-001 is to guide evaluations of new healthcare technologies and practices within the Military Health System to ensure clinical effectiveness and optimize resource use.
Step-by-step explanation:
The purpose of DHA-IPM 18-001 is to establish a standardized process and criteria for the Military Health System (MHS) to ensure that products, medications, and medical services are evaluated based on their clinical effectiveness, health outcomes, and overall value. This is part of the effort to both optimize patient care and manage healthcare costs effectively. DHA-IPM 18-001, which stands for Defense Health Agency Interim Procedures Memorandum 18-001, is a procedural document used within the Department of Defense's healthcare system, specifically within the MHS.
This document guides the assessment and potential adoption of new healthcare technologies, pharmaceuticals, and clinical practices to ensure that they meet stringent effectiveness and cost-value criteria before they are widely implemented. By following this memorandum, healthcare providers and decision-makers in the MHS can make well-informed choices that improve patient outcomes while also contributing to the efficient use of resources.